Ownership history in NATIXIS · 6 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in REPLIGEN CORP (RGEN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 2,586 | +2,236 | +638.9% | 0.00% | $346K | $133.67 |
| 2025 Q2 | REDUCED | 350 | -4,215 | -92.3% | 0.00% | $44K | $124.38 |
| 2025 Q1 | REDUCED | 4,565 | -111,487 | -96.1% | 0.00% | $580K | $127.24 |
| 2023 Q2 | ADDED | 116,052 | +109,491 | +1668.8% | 0.13% | $16.4M | $141.46 |
As of 2025 Q4 — sorted by position size